N4 Pharma Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Nigel Theobald
Chief executive officer
UK£82.5k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 10.5yrs |
| CEO ownership | 4.3% |
| Management average tenure | 5.2yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
Companies Like N4 Pharma (LON:N4P) Are In A Position To Invest In Growth
Oct 11
Here's Why We're Not Too Worried About N4 Pharma's (LON:N4P) Cash Burn Situation
Jul 06Should Shareholders Have Second Thoughts About A Pay Rise For N4 Pharma Plc's (LON:N4P) CEO This Year?
Mar 18Here's What We Think About N4 Pharma's (LON:N4P) CEO Pay
Mar 01Companies Like N4 Pharma (LON:N4P) Can Afford To Invest In Growth
Dec 07
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | UK£83k | UK£83k | -UK£1m |
| Sep 30 2023 | n/a | n/a | -UK£1m |
| Jun 30 2023 | n/a | n/a | -UK£925k |
| Mar 31 2023 | n/a | n/a | -UK£977k |
| Dec 31 2022 | UK£78k | UK£78k | -UK£1m |
| Sep 30 2022 | n/a | n/a | -UK£1m |
| Jun 30 2022 | n/a | n/a | -UK£1m |
| Mar 31 2022 | n/a | n/a | -UK£1m |
| Dec 31 2021 | UK£75k | UK£75k | -UK£2m |
| Sep 30 2021 | n/a | n/a | -UK£2m |
| Jun 30 2021 | n/a | n/a | -UK£2m |
| Mar 31 2021 | n/a | n/a | -UK£2m |
| Dec 31 2020 | UK£72k | UK£72k | -UK£1m |
| Sep 30 2020 | n/a | n/a | -UK£1m |
| Jun 30 2020 | n/a | n/a | -UK£863k |
| Mar 31 2020 | n/a | n/a | -UK£869k |
| Dec 31 2019 | UK£70k | UK£70k | -UK£876k |
| Sep 30 2019 | n/a | n/a | -UK£1m |
| Jun 30 2019 | n/a | n/a | -UK£1m |
| Mar 31 2019 | n/a | n/a | -UK£1m |
| Dec 31 2018 | UK£70k | UK£70k | -UK£1m |
Compensation vs Market: Nigel's total compensation ($USD104.29K) is below average for companies of similar size in the UK market ($USD357.42K).
Compensation vs Earnings: Nigel's compensation has increased whilst the company is unprofitable.
CEO
Nigel Theobald (60 yo)
10.5yrs
Tenure
UK£82,500
Compensation
Mr. Nigel James Theobald has been Chief Executive Officer of N4 Pharma Plc since May 3, 2017 and serves as its Executive Director. Mr. Theobald served as the Head of Emerge Marketing Ltd., for Alltracel Ph...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 10.5yrs | UK£82.50k | 4.3% £ 72.2k | |
| Executive Director & Technical Director | 5.2yrs | UK£51.22k | no data | |
| Executive Director | 4yrs | UK£45.72k | 0.036% £ 607.2 | |
| Head of CMC Development | 4.4yrs | no data | no data | |
| Consultant | 5.5yrs | no data | no data |
5.2yrs
Average Tenure
60yo
Average Age
Experienced Management: N4P's management team is seasoned and experienced (5.2 years average tenure).